Individuals with elevated LDL-cholesterol levels have an increased risk for cardiovascular disease. Despite lipid lowering strategies, however, a significant cardiovascular risk remains. Bekkering et al. show that monocytes from patients with familial hypercholesterolemia have a trained immunity phenotype and that lipid lowering with statins does not revert this pro-inflammatory phenotype.

Additional Metadata
Persistent URL,
Journal Cell Metabolism
Rights No Subscription
Bekkering, S. (Siroon), Stiekema, L.C.A. (Lotte C.A.), Bernelot Moens, S. (Sophie), Verweij, S.L. (Simone L.), Novakovic, B. (Boris), Prange, K. (Koen), … Riksen, N.P. (Niels P.). (2019). Treatment with Statins Does Not Revert Trained Immunity in Patients with Familial Hypercholesterolemia. Cell Metabolism, 30(1), 1–2. doi:10.1016/j.cmet.2019.05.014